Other Antibiotics

  • D. Kraft
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 63)

Abstract

In addition to the penicillins and cephalosporins, many other substances with antibiotic properties are known and widely used. Substances in this group include the tetracyclines, chloramphenicol and thiamphenicol, aminoglycosides, polymyxins, rifamycins, macrolides, lincomycins, and other miscellaneous compounds. These antibiotics are used in the systemic and topical treatment of infectious diseases. Some of these antibiotics have also been used to stimulate growth in animals; they may still be in use now and may therefore persist in the environment.

Keywords

Tuberculosis Streptomycin Streptomyces Kanamycin Dermatitis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Acker R, Schreier K (1962) Erfahrungen mit der Chloramphenicolbehandlung von 3 648 Patienten einer Kinderklinik. Med Klin 57:474–479PubMedGoogle Scholar
  2. Aquinas M, Allan WGL, Horsfall PAL et al. (1972) Adverse reactions to daily and intermittent rifampicin regimens for pulmonary tuberculosis in Hong Kong. Br Med J 1:765–771PubMedCrossRefGoogle Scholar
  3. Autran P, Kaplanski S, Dugue P, Arnaud A, Charpin J (1973) Un cas d’accident d’origine immuno-allergique avec purpura thrombocytopenigue du à la rifampicine. Mars Med 10:845–851Google Scholar
  4. Basler RSW (1976) Potential hazards of clindamycin in acne therapy. Arch Dermatol 112:383–385PubMedCrossRefGoogle Scholar
  5. Bassi L, Di Berardino L, Silvestri LG (1976) IgE antibodies in patients allergic to rifampicin. Int Arch Allergy Appl Immunol 51:390–394PubMedCrossRefGoogle Scholar
  6. Bean SF (1971) Acneiform eruption from tetracycline. Br J Dermatol 85:585–586PubMedCrossRefGoogle Scholar
  7. Beaty HN, Petersdorf RG (1966) Iatrogenic factors in infectious disease. Ann Intern Med 65:641–656PubMedGoogle Scholar
  8. Beck EA (1975) Chloramphenicol- und Thiamphenicolschäden des Bluts. Schweiz Med Wo-chenschr 105:1078–1080Google Scholar
  9. Bedford PD (1951) Idiosyncrasy to aureomycin. Br Med J 2:1428–1429CrossRefGoogle Scholar
  10. Beirne GJ, Hansing CE, Octaviano GN, Bums RO (1967) Acute renal failure caused by hypersensitivity to polymyxin B sulfate. JAMA 202:62–64CrossRefGoogle Scholar
  11. Bennett AH (1965) Antibiotic allergies. JAMA 194:569PubMedCrossRefGoogle Scholar
  12. Berté SJ, Di Mase ID, Christianson CS (1964) Iosoniazid para-aminosalicylic acid and streptomycin intolerance in 1,714 patients. Am Rev. Respir Dis 90:598–606PubMedGoogle Scholar
  13. Blajchman MA, Lowry RC, Pettit JE, Stradling P (1970) Rifampicin-induced immune thrombocytopenia. Br Med J 3:24–26PubMedCrossRefGoogle Scholar
  14. Blank H, Cullen SI, Cataland PM (1968) Photosensitivity studies with demethyl-chlortetra-cycline and doxycycline. Arch Dermatol 97:1–2PubMedCrossRefGoogle Scholar
  15. Bojs G, Möller H (1974) Eczematous contact allergy to Oxytetracycline with cross-sensitivity to other tetracyclines. Berufsdermatosen 22:202–208PubMedGoogle Scholar
  16. Boman G, Nilsson BS, Saerens EJ (1973) Protein binding of rifampicin. Scand J Respir Dis [Suppl] 84:40–44Google Scholar
  17. Boonen W, Van Waveren JW, Hogervorst A (1964) Hypersensitivity to antibiotics. Dermatologica 128:394–409PubMedCrossRefGoogle Scholar
  18. Braun P (1969) Editorial: hepatoxicity of erythromycin. J Infect Dis 119:300–306PubMedCrossRefGoogle Scholar
  19. Braun W, Schütz R (1969) Beitrag zur Gentamycin-Allergie. Hautarzt 20:108–112PubMedGoogle Scholar
  20. Bridges RA, Berendes H, Good RA (1957) Serious reactions to novobiocin. J Pediatr 50:579PubMedCrossRefGoogle Scholar
  21. Brown ST (1974) Tetracycline balanitis: fixed drug reaction. JAMA 227:801PubMedCrossRefGoogle Scholar
  22. Businco L, Lendvai D, Cardi E (1968) Reazione allergica alla tetraciclina e sindrome della „bulging fontanel“ in un bambino di quaranta giorni: sensibilizzazione attraverso il latte materno. Acta Paediatr Lat 21:834–838Google Scholar
  23. Cahill KM (1962) Chloramphenicol hypersensitivity. A severe haemorrhagic reaction. Lancet 2:277–278PubMedCrossRefGoogle Scholar
  24. Calnan CD, Sarkany I (1958) Contact dermatitis from neomycin. Br J Dermatol 70:435–445PubMedCrossRefGoogle Scholar
  25. Campese VM, Marzullo F, Schena FP, Coratelli P (1973) Acute renal failure during intermittent rifampicin therapy. Nephron 10:256–260PubMedCrossRefGoogle Scholar
  26. Carpenter G (1975) Chloramphenicol eye-drops and marrow aplasia. Lancet 2:326–327PubMedCrossRefGoogle Scholar
  27. Cayley FE, Majundar SK (1976) Ocular toxicity due to rifampicin reversible. Br Med J 1:199–200PubMedCrossRefGoogle Scholar
  28. Chakravarty S, Sircar DK (1961) Allergic reactions due to streptomycin: corroboration of clinical findings with streptomycin skin tests. Acta Tuberc Scand 41:144–148Google Scholar
  29. Chung CW, Carson TR (1976) Cross-sensitivity in common aminoglycoside antibiotics. Arch Dermatol 112:1101–1107PubMedCrossRefGoogle Scholar
  30. Chyrek-Borowska S, Kama T, Obrzut D (1973) Leukocyte migration inhibition tests in investigations of allergy to treptomycin. Pol Tyg Lek 28:1536–1540PubMedGoogle Scholar
  31. Coles RB, Philips J, Nuttall JB (1967) Anaphylactoid reaction to demethyl-chlortetracycline (Ledermycin). Br Med J 2:313–314CrossRefGoogle Scholar
  32. Coskey RJ (1978) Contact dermatitis due to clindamycin. Arch Dermatol 114:446PubMedCrossRefGoogle Scholar
  33. Crawford LV, Roane J (1969) Use of erythromycin ethylsuccinate in allergic children. Ann Allergy 27:18–22PubMedGoogle Scholar
  34. Cronin EE (1972) Contact dermatitis XVII. Reactions to contact allergens given orally or systemically. Br J Dermatol 86:104–107PubMedCrossRefGoogle Scholar
  35. Csonka GW, Rosedale N, Walkden L (1971) Balanitis due to fixed frug eruption associated with tetracycline therapy. Br J Vener Dis 47:42–44PubMedGoogle Scholar
  36. Dajani BM, Canady MS, Thompson JS, Kasik JE (1972) Rifampicin: an immunosuppressant? Lancet 2:1094PubMedCrossRefGoogle Scholar
  37. Davies RJ, Pepys J (1975) Asthma due to enhaled chemical agents — the macrolide antibiotic spiramycin. Clin Allergy 5:99–107PubMedCrossRefGoogle Scholar
  38. Day HJ, Conrad FG, Moore JE (1958) Immunothrombocytopenia induced by novobiocin. Am J Med Sci 236:475PubMedGoogle Scholar
  39. Delaney TJ (1970) Tetracycline-induced fixed drug eruptions. Br J Dermatol 83:357–358PubMedCrossRefGoogle Scholar
  40. Dewdney JM (1977) Immunology of the antibiotics. In: Sela M (ed) The antigens IV. Academic Press, New York San Francisco London, pp 73–245Google Scholar
  41. Dobozy A, Hunyadi J, Simon H (1971) Demonstration of chloramphenicol hypersensitivity by measurement of histone methylation in lymphocyte cultures. Clin Exp Immunol 8:917–925PubMedGoogle Scholar
  42. Dohn W (1962) Testanalytische Untersuchungen zur Frage der relativen Häufigkeit von Antibiotika-Kontaktallergien. Arzneim Forsch 12:601–606Google Scholar
  43. Dukor P, Schumann G, Dietrich FM (1973) Immunological studies with rifampicin. Scand J Respir Dis [Suppl] 84:73–82Google Scholar
  44. Duncan WC, Holder WR, Roberts DP, Knox JM (1972) Treatment of gonorrhoea with spectinomycin hydrochloride: comparison with standard penicillin schedules. Antimicrob Agents Chemother 1:210–214PubMedGoogle Scholar
  45. Eberhartinger C, Ebner H (1966) Beitrag zur Kenntnis der Kontaktallergie durch Chloramphenicol. Arch Klin Exp Dermatol 224:463–470PubMedCrossRefGoogle Scholar
  46. Ebner H (1973) Kontaktallergie gegen Antibiotika. Wien Klin Wochenschr 85:203–204PubMedGoogle Scholar
  47. Editorial (1965) Anaphylactic reaction to tetracycline. JAMA 192:992Google Scholar
  48. Editorial (1970) Chloramphenicol-induced bone marrow suppression. JAMA 213:1183–1184Google Scholar
  49. Editorial comments and conclusions Boman G, Nilsson BS, Saevens EJ (1973) Stockholm workshop on rifampicin 1972. Scand J Respir Dis [Suppl] 84:192–193Google Scholar
  50. Editorial (1977) Topical antibiotics. Br Med J 1:1494Google Scholar
  51. Epstein S (1956) Contact dermatitis from neomycin due to dermal delayed (tuberculin-type) sensitivity. Dermatologica 113:191–201PubMedCrossRefGoogle Scholar
  52. Epstein E, Panzer JD (1971) Neomycin sensitivity. Arch Dermatol 103:562PubMedCrossRefGoogle Scholar
  53. Epstein S, Wenzel FJ (1962) Cross-sensitivity to various “mycins”. Arch Dermatol 86:183–194PubMedGoogle Scholar
  54. Fawcett IW, Pepys J (1976) Allergy to a tetracycline preparation — a case report. Clin Allergy 6:301–304PubMedCrossRefGoogle Scholar
  55. Fellner MJ, Baer RC (1965) Anaphylactic reaction to tetracycline in a penicillin-allergic patient. JAMA 192:997–998PubMedGoogle Scholar
  56. Fellner MJ, Baer RL (1966) Immunologic studies in a patient sensitive to tetracycline and penicillin. Arch Klin Exp Dermatol 224:157–167PubMedCrossRefGoogle Scholar
  57. Fisher AA (1966) Systemic eczematous “contact type” dermatitis medicamentosa. Ann Allergy 24:406–410PubMedGoogle Scholar
  58. Fisher AA (1976 a) Erythromycin: a nonsensitizing topical antibiotic. Arch Dermatol 112:732PubMedCrossRefGoogle Scholar
  59. Fisher AA (1976 b) The safety of topical erythromycin. Contact Dermatitis 2:43–45PubMedCrossRefGoogle Scholar
  60. Förström L, Pirilä V (1978) Cross-sensitivity within the neomycin group of antibiotics. Contact Dermatitis 4:312PubMedCrossRefGoogle Scholar
  61. Forck G (1971) Häufigkeit und Bedeutung von Chloramphenicol-Allergien. Dtsch Med Wochenschr 96:161–165PubMedCrossRefGoogle Scholar
  62. Fraki JE, Peltonen L, Hopsu-Hava VK (1979) Allergy to various components of topical preparations in stasis dermatitis and leg ulcer. Contact Dermatitis 5:98–100CrossRefGoogle Scholar
  63. Friedberg CK, Rosen KM, Bienstock PA (1968) Vancomycin therapy for enterococcae and streptococcus viridans endocarditis. Arch Intern Med 122:134–138PubMedCrossRefGoogle Scholar
  64. Frost P, Weinstein GD, Gomez EC (1971) Methacycline and demeclocycline in relation to sunlight. JAMA 216:326–327PubMedCrossRefGoogle Scholar
  65. Furey WW, Tan C (1969) Anaphylactic shock due to demethylchlortetracycline. Ann Intern Med 70:357–385PubMedGoogle Scholar
  66. Fulghum DD, Catalano PM (1973) Stevens-Johnson syndrome from clindamycin. A case report. JAMA 223:318–319Google Scholar
  67. Gange RW, Rhodes EL, Edwards CO, Powell MEA (1976) Pemphigus induced by rifampian. Br J Dermatol 95:445–448PubMedCrossRefGoogle Scholar
  68. Geddes AM, Bridgwater FAJ, Williams DN, Don J, Grimshaw GJ (1970) Clinical and bacteriological studies with clindamycin. Br Med J 2:703–704PubMedCrossRefGoogle Scholar
  69. Geraci JE (1977) Vancomycin. Mayo Clin Proc 52:631–634Google Scholar
  70. Gilbert FI (1962) Cholestatic hepatitis caused by esters of erythromycin and oleandomycin. JAMA 182:1048–1051PubMedGoogle Scholar
  71. Girard JP (1974) Diagnostic tests in drug allergy. In: Yamamura Y et al. (eds) Allergology. Excerpta Medica, Amsterdam London New York, pp 460–466Google Scholar
  72. Girard JP, Schwartz H (1967) Serum hemagglutinating antibodies in streptomycin allergy. Med Pharmacol Exp 17:466–474Google Scholar
  73. Girling DJ (1977) Adverse reactions to rifampicin in antituberculosis regimens. J Antimicrob Chemother 3:115–132PubMedCrossRefGoogle Scholar
  74. Girling DJ, Hitze KL (1979) Adverse reactions to rifampicin. Bull WHO 57:45–50PubMedGoogle Scholar
  75. Grater WC (1962) Allergic reactions to oral antibacterials in hypersensitive patients. Ann Allergy 20:480–485PubMedGoogle Scholar
  76. Greenberg M, Greenspan W (1962) Anaphylactoid reaction to demethyl-chlortetracycline hydrochloride. JAMA 181:454Google Scholar
  77. Grudzinski W (1960) Death following a test injection of dihydrostreptomycin. Bull Pol med Hist Sci 13:139–140Google Scholar
  78. Haas R (1957) Anaphylactoid reaction to oral tetracycline. J Maine Med Assoc 48:85–86PubMedGoogle Scholar
  79. Halpern B, Ky NT, Amache N (1967) Diagnosis of drug allergy in vitro with the lymphocyte transformation test. J Allergy 40:168–181PubMedCrossRefGoogle Scholar
  80. Hamburger RN (1966) Chloramphenicol-specifie antibody. Science 152:203–205PubMedCrossRefGoogle Scholar
  81. Hamburger RN, Douglass JH (1969 a) Chloramphenicol-specific antibody. II. Reactivity to analogues of chloramphenicol. Immunology 17:587–592PubMedGoogle Scholar
  82. Hamburger RN, Douglass JH (1969b) Chloramphenicol-specifie antibody. III. Differential Ab decay rates to separate determinants on one antigen. Immunology 17:593–598PubMedGoogle Scholar
  83. Hamburger RN, Douglass JH (1969 c) Chloramphenicol-specifie antibody. IV. Neutralization of antibiotic effect on escherichia coli. Immunology 17:599–602PubMedGoogle Scholar
  84. Hashimoto Y, Sasaki H, Yoshinari M, Iwatsuki K (1976) Myasthenia gravis and antibiotics. Jpn J Anesthesiol 26:143–147Google Scholar
  85. Hasse W, Pohle MD, Warnecke F, Weik K (1971) Hämatologische Krise durch Rifampicin. Prax Pneumol 25:466–468PubMedGoogle Scholar
  86. Herrmann H, Eule H (1973) Immunological and haematological investigations on patients with adverse reactions during treatment with RMP plus INH once-weekly. Scand J Respir Dis [Suppl] 84:87–93Google Scholar
  87. Herstoff JK (1978) Sensitization to topical antibiotics. Arch Dermatol 114:1402PubMedCrossRefGoogle Scholar
  88. Hewitt WL (1974) Gentamycin: toxicity in perspective. Postgrad Med J [Suppl 7] 50:55–62PubMedGoogle Scholar
  89. Hoeprich PD (1970) The polymyxins. Med Clin North Am 54:1257–1271PubMedGoogle Scholar
  90. Hoffmann DR (1970) Model systems for the study of drug hypersensitivity. PhD thesis, California Institute of Technology, Pasadena, California. Published by Xerox University Microfilms, Ann Arbor, MichiganGoogle Scholar
  91. Hoigné R (1975) Penicillins, cephalosporins and tetracyclines. In: Meyler’s side effects of drugs, VIII. Excerpta Medica, Amsterdam London New YorkGoogle Scholar
  92. Homberg JC, Pujet JC, Salmon C (1973) A study of rifampicin antigenic site. Scand J Respir Dis 84:36–39Google Scholar
  93. Hong Kong Tuberculosis Treatment Services/British Medical Research Council Investigation (1975) Investigations of allergic status and blood counts in Chinese patients receiving daily or intermittent rifampicin in Hong Kong. Clin Allergy 5:189–199CrossRefGoogle Scholar
  94. Hutfield DC (1965) Streptomycin sensitization. Br J Vener Dis 41:210–212PubMedGoogle Scholar
  95. Hysell JK, Gray JM, Hysell JW, Beck ML (1975) An antineomycin antibody interfering with ABO grouping and antibody screening. Transfusion 15:16–22PubMedCrossRefGoogle Scholar
  96. Jacottet M (1964) Panmyelophthise et anticorps antichloromycétine. Arch Fr Pediatr 21:218–221PubMedGoogle Scholar
  97. John W (1960) Kontaktallergien gegen Antibiotika. Hautarzt 11:433–440Google Scholar
  98. Johnston TG, Cazort AG (1953) Severe serum-sickness reaction with cyanosis following terramycin. Antibiot Chemother 3:481Google Scholar
  99. Kaltwasser JB, Simon B, Werner E, Stille W, Becker H (1974) Untersuchungen zur Hämatotoxizität von Thiamphenicol. Arzneim Forsch 24:190–194Google Scholar
  100. Kandil E (1969) Fixed drug eruption. Dermatologica 139:37–40PubMedCrossRefGoogle Scholar
  101. Kandra T, Baris I, Kolacan B (1978) Rifampicin-dependent antibodies in a patient with hepatorenal failure. Br J Dis Chest 72:67–70CrossRefGoogle Scholar
  102. Keiser G, Bolli P, Buchegger U (1972) Hämatologische Nebenwirkungen von Chloramphenicol und Thiamphenicol. Schweiz Med Wochenschr 102:1595–1598PubMedGoogle Scholar
  103. Ketel WG van (1976) Immediate- and delayed-type allergy to erythromycin. Contact Dermatitis 2:363–364PubMedCrossRefGoogle Scholar
  104. Kleine-Natrop HE (1956) Antibiotika als berufliche Antigene in der Arzneimittelindustrie. Berufsdermatosen 4:269–276Google Scholar
  105. Kleinknecht D, Homberg JC, Decroix G (1972) Acute renal failure after rifampicin. Lancet 1:1238–1239PubMedCrossRefGoogle Scholar
  106. Kligman AM (1967) The idendification of contact allergens by human assay. J Invest Dermatol 47:393–409Google Scholar
  107. Koch-Weser J (1970) Adverse effects of sodium colistimethate. Ann Intern Med 72:857–859PubMedGoogle Scholar
  108. Koch-Weser J, Gilmore EB (1967) Benign intracranial hypertension in an adult after tetracycline therapy. JAMA 200:345–347PubMedCrossRefGoogle Scholar
  109. Koolj R (1961) Allergic contact dermatitis due to neomycin: Cross-sensitivity with other antibiotics and positive patch tests with the isomeric compounds neomycin B and C and with neamine. S Afr Med J 20:406–411Google Scholar
  110. Korossy S (1976) Drug allergy. In: Rajka E, Korossy S (eds) Immunological aspects of allergy and allergic diseases, vol 7. Plenum, New York London, pp 179–294Google Scholar
  111. Korossy S, Vineze E, Gozony M (1962) Durch Chloramphenicolbehandlung verursachte Allergodermatosen. Allerg Asthma (Leipz) 8:228–232Google Scholar
  112. Korossy S, Vincze E, Gozony M (1966) Chloramphenicol (Chlorocid)-Allergic Z Hautkr 41:375–379Google Scholar
  113. Korossy S, Vincze E, Doroszlay G, Munkaćsi A (1969) Zur Revision des Allergenspektrums der in Ungarn gebräuchlichen diagnostischen Standard-Reihe für Epikutantestung. Berufsdermatosen 17:252–263PubMedGoogle Scholar
  114. Kounis NG (1975) Oxytetracycline-induced thrombocytopenic purpura. JAMA 231:734–735PubMedCrossRefGoogle Scholar
  115. Kreis B (1966) Kanamycin toxicity in adults. Ann NY Acad Sci 132/2:957PubMedCrossRefGoogle Scholar
  116. Krönig B, Fiegel P, Weihrauch T, Hoffler D, Jahnecke J, Arndthauser A (1972) A case of severe repeated immunological reactions to intermittent rifampicin treatment. Eur J Clin Pharmacol 5:53–57CrossRefGoogle Scholar
  117. Kucers A, Bennet NMcK (1975) The use of antibiotics, 2nd edn. Heinemann, LondonGoogle Scholar
  118. Kuder HV (1960) Propionyl erythromycin. A review of 20,525 case reports for side effect data. Clin Pharmacol Ther 1:604–609PubMedGoogle Scholar
  119. Lachman SJ (1959) Anaphylactic reaction to oral Chlortetracycline. Antibiot Med 6:62Google Scholar
  120. Lakin JD, Grace WR, Sell KW (1975 a) IgE antipolymyxin B antibody formation in a T cell-depleted bone marrow transplant patient. J Allergy 56:94–103Google Scholar
  121. Lakin JD, Strong DM, Sell KW (1975 b) Polymyxin B reactions, IgE antibody and T cell deficiency. Ann Intern Med 83:204–207PubMedGoogle Scholar
  122. Lakshminarayan S, Sahn AS, Hudson LD (1973) Massive haemolysis caused by rifampicin. Br Med J 2:282–283PubMedCrossRefGoogle Scholar
  123. Langunoff D, Benditt BP (1960) Mast cell degranulation and histamine release observed in a new in vitro system. J Exp Med 112:571–580CrossRefGoogle Scholar
  124. Lazzaro C, Buzzoni A (1968) Il test della trasformazione blastica dei linfociti nell’allergia agli antibiotici. Minerva Med 59:4785–4788PubMedGoogle Scholar
  125. Lewis JE, Nelson JC, Elder HA (1972) Radioimmunoassay of an antibiotic: gentamycin. Nature New Biol 239:214–216PubMedGoogle Scholar
  126. Lochmann O, Kohout P, Vymola F (1977) Anaphylactic shock following the administration of clindamycin. J Hyg Epidemiol Microbiol Immunol (Praha) 21:441–447Google Scholar
  127. Lochmannova J, Benis J, Lochmann O, Vymola F (1970) On the immunological reactivity of penicillin, cephalosporin and tetracycline antibiotics. J Hyg Epidemiol Microbiol Immunol (Praha) 14:201–210Google Scholar
  128. MacFarlane JA, Mitchell AAB, Walsh JM, Robertson JJ (1968) Spiramycin in the prevention of post-operative staphylococcal infection. Lancet 1:1–4PubMedCrossRefGoogle Scholar
  129. Manten A (1975) Antibiotic drugs. In: Dukes MNG (ed) Meyler’s side effects of drugs. Excerpta Medica, Amsterdam London New York, pp 603–647Google Scholar
  130. Manten A (1978) Other antibiotics. In: Dukes MNG (ed) Side effects of drugs, annual 2. Excerpta Medica, Amsterdam London New York, pp 231–240Google Scholar
  131. Manten A (1979) Other antibiotic drugs. In: Dukes MNG (ed) Side effects of drugs, annual 3. Excerpta Medica, Amsterdam London New York, pp 226–235Google Scholar
  132. Marschke G, Sarauw A (1971a) Polymyxin inhalation — therapeutic hazard. Ann Intern Med 74:144–145PubMedGoogle Scholar
  133. Marschke G, Sarauw A (1971b) Danger of polymyxin B inhalation. Ann Intern Med 74:296–297PubMedGoogle Scholar
  134. Martinez J, Lletona L, Barbolla L, Frieyro E, Bouza E, Gilsanz F (1977) Immune haemolytic anaemia and renal failure induced by streptomycin. Br J Haematol 35:561–571CrossRefGoogle Scholar
  135. Mathews KP, Pan PM, Wells JH (1972) Experience with lymphocyte transformation tests in evaluating allergy to aminosalicylic acid, isoniazid and streptomycin. Int Arch Allergy Appl Immunol 42:653–667CrossRefGoogle Scholar
  136. Matner T (1969) Ekzematöse Sensibilisierung durch Neomycin. Hautarzt 20:446–450PubMedGoogle Scholar
  137. Mattson K (1973) Side effects of rifamycin. A clinical study. Scand J Respir Dis 82:1–52Google Scholar
  138. Maucher OM (1972) Anaphylaktische Reaktionen beim Epicutantest. Hautarzt 23:139–140PubMedGoogle Scholar
  139. Maulide I, Villar TG (1974) Therapeutic trial with clindamycin in non-tuberculosis infections of the respiratory tract. Pneumologia (Lisbon) 5:79–82Google Scholar
  140. Melnikova EA (1971) Experimental study of the sensitizing properties of the antibiotics phytobacteriomyxin and polymyxin. Antibiotiki 16:911Google Scholar
  141. Menon MPS, Das AK (1977) Tetracycline asthma — a case report. Clin Allergy 7:285–290PubMedCrossRefGoogle Scholar
  142. Miller R, Tausk HC (1977) Anaphylactoid reaction to vancomycin during anesthesia. Anesth Analg (Cleve) 56:870–872Google Scholar
  143. Moehring K, Asbach HW, Schubothe H, Weber S (1974) Hämolytische Krise mit akutem Nierenversagen unter Rifampicin-Behandlung. Dtsch Med Wochenschr 99:1458–1462CrossRefGoogle Scholar
  144. Möller H (1976) Eczematous contact allergy to Oxytetracycline and polymyxin B. Contact Dermatitis 2:289–290PubMedCrossRefGoogle Scholar
  145. Moneret-Vautrin D, Grilliat JP, Pupil P (1972) In: Dash CH, Jones HEH (eds) Mechanisms in drug allergy. Basophil degranulation in drug allergy. Churchill Livingstone, Edinburgh London, pp 159–170Google Scholar
  146. Morison WL, Parrish JA, Epstein JH (1979) Photoimmunology. Arch Dermatol 115:350–355PubMedCrossRefGoogle Scholar
  147. Moser RH (1966) Reactions to tetracycline. Clin Pharmacol Ther 7:117–132Google Scholar
  148. Mühlberger F (1973) Allergie gegen Tuberkulostatika. Schweiz Med Wochenschr 103:126–131PubMedGoogle Scholar
  149. Muelling RJ, Bevent T, Samson RF, Jenevein EP, Guillory JD (1958) Studies in human sensitivity to antibiotics. I. Testing for precipitins after reaction to antibiotics. Am J Clin Pathol 29:503–505PubMedGoogle Scholar
  150. Nachman R, Javid J, Krauss S (1962) Streptomycin-induced hemolytic anemia. Arch Intern Med 110:187–190PubMedGoogle Scholar
  151. Naik RPC, Singli G (1976) Bullous fixed drug eruption presumably due to erythromycin. Dermatologica 152:177–180PubMedCrossRefGoogle Scholar
  152. Nessi R, Domenichini E, Fowst G (1973) Allergic reactions during rifampicin treatment: a review of published cases. Scand J Respir Dis [Suppl] 84:15–19Google Scholar
  153. Nordquist B, Rossman H (1967) Leucocytic migration in vitro as an indicator of allergy in eczematons contact dermatitis. Trans St John’s Hosp Dermatol Soc 53:154–159Google Scholar
  154. Nyirenda R, Gill GV (1977) Stevens-Johnson syndrome due to rifampicin. Br Med J 2:1189PubMedCrossRefGoogle Scholar
  155. Olson CA, Riley HJ Jr (1966) Complications of tetracycline therapy. J Pediatr 68:783–791PubMedCrossRefGoogle Scholar
  156. O’Mahony MG (1973) Observations on antibody reaction scores on individual patients. Scand J Respir Dis [Suppl] 84:64–72Google Scholar
  157. Orgel HA, Hamburger RN (1971) Chloramphenicol antibody. V. A method for the detection of antichloramphenicol antibody in human serum. Immunology 20:233–239PubMedGoogle Scholar
  158. Otten H, Plembel M, Siegenthaler W (1975) Antibiotika-Fibel. Antibiotika und Chemotherapie, 4th edn. Thieme, StuttgartGoogle Scholar
  159. Pambor M (1973) Zur Unterscheidung ekzemallergischer und toxischer Hautentzündungen im Rebuck-Test. Dermatol Monatsschr 159:806–813PubMedGoogle Scholar
  160. Pasricha JS, Shukla SR (1979) Independent lesions of fixed eruptions due to two unrelated drugs in the same patient. Br J Dermatol 101:361–362PubMedCrossRefGoogle Scholar
  161. Patrick J, Panzer JD, Derbes VJ (1970) Neomycin sensitivity in the normal (non-atopic) individual. Arch Dermatol 102:532–535PubMedCrossRefGoogle Scholar
  162. Peck SM, Feldmann FF (1950) Sensitivity reactions to aureomycin. JAMA 142:1137–1139Google Scholar
  163. Pedersen AHB, Wiesner PJ, Holmes KK, Johnson CJ, Turck M (1972) Spectinomycin and penicillin G in the treatment of gonorrhoea. A comparative evaluation. JAMA 220:205–208PubMedCrossRefGoogle Scholar
  164. Petrescu D, Marca G, Veronese M (1972) Humoral antibody production following primary and secondary immunization in rabbits treated with thiamphenicol and chloramphenicol. Antibiot Chemother 17:200–216Google Scholar
  165. Pevny I, Röckl H (1975) Arzneimittelbedingte allergische Hautreaktionen vom kutan-vas-culären Typ. MMW 117:9–16Google Scholar
  166. Pirilä V, Pirilä L (1966) Sensitization to the neomycin group of antibiotics: patterns of cross-sensitivity as a function of polyvalent sensitization to different portions of the neomycin molecule. Acta Derm Venereol (Stockh) 46:489–496Google Scholar
  167. Pirilä V, Rouhunkoski S (1960) On cross-sensitization between neomycin, bacitracin, kanamycin, and framycetin. Dermatologica 121:335–342PubMedCrossRefGoogle Scholar
  168. Pitmann FE, Pittman JC, Humphrey CD (1974) Lincomycin and pseudomembranous colitis. Lancet 1:451–452CrossRefGoogle Scholar
  169. Pla RP, Martin C (1976) Anemie hemolytique immuno-allergique liée à la streptomycine. Rev Fr Transfus Immunohematol 19:379–382PubMedCrossRefGoogle Scholar
  170. Poole G, Stradling P, Worlledge S (1971) Potentially serious side effects of high dose twice weekly rifampicin. Br Med J 3:343–347PubMedCrossRefGoogle Scholar
  171. Pollen RH (1964) Anaphylactoid reaction to orally administered demethylchlortetracycline. N Engl J Med 271:673PubMedCrossRefGoogle Scholar
  172. Prasad AS (1960) Severe urticaria following erythromycin therapy. N Engl J Med 262:139–140CrossRefGoogle Scholar
  173. Preyss JA von (1969) Allergie gegen Tylosin Tartrat. Berufsdermatosen 17:166–167Google Scholar
  174. Pujet JC, Homberg JC, Decroix G (1974) Sensitivity to rifampicin: incidence, mechanisms and prevention. Br Med J 2:415–418PubMedCrossRefGoogle Scholar
  175. Queng JT, Dukes CD, McGovern JP (1965) Antigenicity of the tetracyclines. J Allergy 36:505–513PubMedCrossRefGoogle Scholar
  176. Raab W (1968) Mast cell depleting properties of neomycin. J Invest Dermatol 50:138–140PubMedGoogle Scholar
  177. Raab W (1975) Spectinomycin. Indikationen und unerwünschte Wirkungen. Schweiz Med Wochenschr 105:1116–1123PubMedGoogle Scholar
  178. Raab W (1977) Untersuchungen zur Frage akuter unerwünschter Wirkungen von Erythromycin, Lincomycin u. Clindamycin. Int J Clin Pharmacol 15:90–97Google Scholar
  179. Ramsay CA (1977) Longwave UV radiation sensitivity induced by Oxytetracycline. A case report. Clin Exp Dermatol 2:255–258PubMedCrossRefGoogle Scholar
  180. Rasmussen F (1972) Side effects of streptomycin sulphate. Scand J Respir Dis 53:35–37PubMedGoogle Scholar
  181. Reichenberger M, Heitmann HJ (1969) Lymphocyte transformation in patients allergic to ampicillin and tetracycline. Lancet 2:491–492PubMedCrossRefGoogle Scholar
  182. Richter G (1975) Zur Kritik der externen Dermatika unter dem Aspekt ihrer allergischen Nebenwirkungen. Dermatol Monatsschr 161:384–387PubMedGoogle Scholar
  183. Ripps CS, Fellner MJ, Hirschhorn K (1965) Response of lymphocytes to tetracycline. Lancet 1:951–952CrossRefGoogle Scholar
  184. Robinson HM Jr, Zeligman I, Shapiro A, Cohen MM (1951) Acquired contact sensitivity to Chloromycetin. J Invest Dermatol 17:205–206PubMedGoogle Scholar
  185. Rocklin RE, David JR (1971) Detection in vitro of cellular hypersensitivity to drugs. J Allergy Clin Immunol 48:276–282PubMedCrossRefGoogle Scholar
  186. Rosenthal RL, Blackman A (1965) Bone-marrow hypoplasia following use of chloramphenicol eye drops. JAMA 191:136–137PubMedGoogle Scholar
  187. Rossen FL (1948) Streptomycin sensitivity. Anaphylactic shock with recovery following intracutaneous test. JAMA 137:1128–1130Google Scholar
  188. Sack K, Freiesleben H, Zueilich B (1978) Beurteilung neuer Aminoglykosid-Antibiotika. Internist Prax 18:443–456Google Scholar
  189. Sakamoto A (1956) Anaphylactoid reaction to intramuscular tetracycline hydrochloride. Report of a case. Calif Med 84:55–56PubMedGoogle Scholar
  190. Sarkany I (1967) Lymphocyte transformation in drug hypersensitivity. Lancet 1:743–745PubMedCrossRefGoogle Scholar
  191. Savage GM (1973) Spectinomycin related to the chemotherapy of gonorrhea. Infection 1:227–228PubMedCrossRefGoogle Scholar
  192. Scheegans E, Haarschar A, Kuntzmann F (1965) Agranulocytose Mortelle après traitement au chloramphnicol. Recherche d’anticorps. Arch Fr Pediatr 22:216–219PubMedGoogle Scholar
  193. Schindel LE (1965) Clinical side-effects of the tetracyclines. Antibiot Chemother 13:300–316PubMedGoogle Scholar
  194. Schindel L (1966) Klinisch beobachtete Nebenwirkungen neuerer AB. Novobiocin-Polymyxin. Ther Umsch 23:341–345PubMedGoogle Scholar
  195. Schoenfeld MR (1964) Vascular purpura caused by Oxytetracyclin. JAMA 188:328–329PubMedGoogle Scholar
  196. Schorr WF, Ridgway HB (1977) Tobramycin-neomycin cross-sensitivity. Contact Dermatitis 3:133–137PubMedCrossRefGoogle Scholar
  197. Schorr WF, Wenzel FJ, Hegedus SI (1973) Cross-sensitivity and aminoglycoside antibiotics. Arch Dermatol 107:533–539PubMedCrossRefGoogle Scholar
  198. Schubothe H, Weber S (1973) Rifampicin-dependent reactions against erythrocytes in the sera of patients receiving rifampicin therapy. Scand J Respir Dis [Suppl] 84:53–59Google Scholar
  199. Schubothe H, Seufert CD, Weber S (1972) Quinine and rifampicin antibodies with hemolytic effect. Verh Dtsch Ges Inn Med 78:905–908PubMedGoogle Scholar
  200. Schwank R, Jirasek L (1963) Kontaktallergie gegen Chloramphenicol mit besonderer Berücksichtigung der Gruppensensibilisierung. Hautarzt 14:24–30PubMedGoogle Scholar
  201. Scott JL, Finegold SM, Belkin GA, Lawrence JS (1965) A controlled double-blind study of the hematologic toxicity of chloramphenicol. N Engl J Med 272:1137–1141PubMedCrossRefGoogle Scholar
  202. Seufert CD (1973) Acute renal failure after rifampicin therapy. Scand J Respir Dis [Suppl] 84:174–179Google Scholar
  203. Shelley WB (1963) The circulating basophil as an indicator of hypersensitivity in man. Arch Dermatol 88:759–767PubMedGoogle Scholar
  204. Shelley WB (1965) Further experiences with the indirect basophil test. Arch Dermatol 91:165–170CrossRefGoogle Scholar
  205. Shelley WB, Heaton CL (1973) Minocycline sensitivity. JAMA 224:125–126PubMedCrossRefGoogle Scholar
  206. Sherlock S (1965) Hepatic reactions to therapeutic agents. Ann Rev Pharmacol 5:429–446CrossRefGoogle Scholar
  207. Shimizu Y, Shimao S (1977) A case of minocychne-induced fixed drug eruption. J Dermatol (Tokyo) 4:73–76Google Scholar
  208. Sidi E, Hincky M, Longueville R (1958) Cross-sensitization between neomycin and streptomycin. J Invest Dermatol 30:225–231PubMedGoogle Scholar
  209. Simon C, Stille W (1979) Antibiotika — Therapie in Klinik und Praxis. Schattauer, Stuttgart New YorkGoogle Scholar
  210. Singh CV, Grover V, Kamra GL (1977) Fatal anaphylactic reaction to tetracycline in the post-operative period. Anaesthesia 32:268PubMedCrossRefGoogle Scholar
  211. Smith JM (1960) Allergic reactions to anti-tuberculous drugs. Acta Allergol 15:191–195Google Scholar
  212. Sors C, Sarrazin A, Homberg JC (1972) Accidents hémolytique recidivants d’origine immuno-allerque au cours d’un traitement intermittent par la refampicine. Rev Tuberc Pneu-mol 36:405–406Google Scholar
  213. Speirs CT (1976) Tobramycin side effects; international results. Scott Med J 21:178–181Google Scholar
  214. Spektorova AI (1961) Antibiotiki 6:226. Cited by Dedney JM (1977) in: Immunology of the antibiotics. In: Sela (M) ed The antigens, vol IV. Academic Press, New York LondonGoogle Scholar
  215. Stevens EAM, Joniau M, Verbist L (1973) Preliminary data on immunological experiments with rifamycin conjugates. Scand J Respir Dis (Suppl.) 84:36–39Google Scholar
  216. Sulkowski SR, Haserick JR (1964) Simulated systemic lupus erythematosus from degraded tetracycline. JAMA 189:152–154PubMedGoogle Scholar
  217. Terekhova NY, Wushkina TP (1977) The syndrome of erythema exsudativum multiforme as a manifestation of drug allergy. Vestn Dermatol Venerol 10:66–68PubMedGoogle Scholar
  218. Veien NK, Hattel T, Justesen O, Nørholm A (1980) Occupational contact dermatitis due to spiramycin and/or tylosin among farmers. Contact Dermatitis 6:410–413PubMedCrossRefGoogle Scholar
  219. Virgilio R (1973) Rifampicin-dependent antibodies during intermittent treatment. Scand J Respir Dis [Suppl] 84:83–86Google Scholar
  220. Vischer TL (1966) Lymphocyte cultures in drug hypersensitivity. Lancet 2:467–469PubMedCrossRefGoogle Scholar
  221. Vulliemoz P, Favez G (1964) Proprietés antigéniques de la streptomycine. Schweiz Med Wochenschr 94:1252–1256PubMedGoogle Scholar
  222. Wade JC, Petty BG, Conrad G, Smith CR, Liposky JJ, Ellner J, Lietman PS (1978) Cephalotin plus an aminoglycoside is more nephrotoxic than methicillin plus an aminoglycoside. Lancet 2:604–606PubMedCrossRefGoogle Scholar
  223. Wätzig V, Ruffert K (1977) Der Nachweis der Chloramphenicol-Allergie mit dem Leukozyten-Migrations-Hemmtest in der Hautkammer. Allerg Immunol (Leipz) 23:69–78Google Scholar
  224. Wahl D, Menaut P, Roche G (1978) Anuric allergic tubular nephritis to rifampicin. Poumon Coeur 34:437–439PubMedGoogle Scholar
  225. Walker WG (1969) Hypersensitivity reaction in a patient receiving lincomycin. Can Med Assoc J 101:763Google Scholar
  226. Walker RG, Thomson NW, Dowling JP, Ogg CS (1979) Minocychne-induced acute interstitial nephritis. Br Med J 1:524PubMedCrossRefGoogle Scholar
  227. Warrington RJ, Tse KS (1979) Lymphocyte transformation studies in drug hypersensitivity. Can Med Assoc J 120:1089–1094PubMedGoogle Scholar
  228. Watson KC, Joubert SM (1960) Haemagglutination of antibiotic treated cells. Nature 188:505–506PubMedCrossRefGoogle Scholar
  229. Weinstein HI, Welch H (1958/1959) Sensitivity to the tetracyclines. Antibiot Annu pp 643–646Google Scholar
  230. Welsh AL (1955) Crossed fixed drug eruptions from three antibiotics. Arch Dermatol 71:521–523Google Scholar
  231. Wenz B, Klein RL, Lalezari P (1974) Tetracycline-induced immune hemolytic anemia. Transfusion 14:265–269PubMedCrossRefGoogle Scholar
  232. Wenzel FJ, Epstein S (1964) Cross-sensitivity between streptomycin and dihydrostreptomycin. J Invest Dermatol 43:99–101PubMedGoogle Scholar
  233. White GJ (1965) Nonantigenicity of lincomycin. Antimicrob Agents Chemother 398–402Google Scholar
  234. Wiebe JA, Moore DE (1977) Photooxidation sensitized by tetracyclines. J Pharm Sci 66:186–189PubMedCrossRefGoogle Scholar
  235. Willcox RR (1962) Trobicin (actinospectacin) a new injectable antibiotic in the treatment of gonorrhoea. Br J Vener Dis 38:150–153PubMedGoogle Scholar
  236. Winter V, Freund D (1969) Fluoreszenz-immunohistochemische und immunologische Studien bei einem Fall von Tetracyklin-Allergie. Hautarzt 20:74–77PubMedGoogle Scholar
  237. Worlledge S (1973) The detection of rifampicin-dependent antibodies. Scand J Respir Dis [Suppl] 84:60–63Google Scholar
  238. Wullen F, Kast G, Bruck A (1967) Über Nebenwirkungen bei Tetracyclin-Verabreichung an Myasthenikern. Dtsch Med Wochenschr 92:667PubMedCrossRefGoogle Scholar
  239. Zeiger J, Seidl V (1969) Multivalente Antibiotika. Allergie mit Penicillin und Tetracyclin-Anaphylaxie. Dermatologica 139:365–373CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1983

Authors and Affiliations

  • D. Kraft

There are no affiliations available

Personalised recommendations